PPARG and type 2 diabetes mellitus: Compounds 3a, 3b, 4a, 4b, 4c, 4r, 4s, 4x, and 4y selected from the in silico study could be useful for the treatment of T2D and its micro- and macrovascular complications, based on their ADMET properties, as well as the ΔG values obtained with the PPARγ protein.